Headache

Displaying 1 - 10 out of 10 guidelines found

  1. Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache

    April 2016

    Current guideline. Endorsed by the American Association of Neuromuscular & Electrodiagnostic Medicine and by the American Society of Plastic Surgeons.

  2. Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults

    April 2012

    Current guideline. Reaffirmed on July 18, 2015. Endorsed by the American Osteopathic Association and by the International Headache Society.

  3. Update: NSAIDs and Other Complementary Treatments for Episodic Migraine Prevention in Adults

    April 2012

    Retired by the AAN Institute Board of Directors on September 16, 2015.

  4. Acute and Preventive Pharmacologic Treatment of Cluster Headache

    August 2010

    Systematic review. Endorsed by the AAN.

  5. Botulinum Neurotoxin in the Treatment of Autonomic Disorders and Pain

    May 2008

    Update in progress. Endorsed by the American Academy of Physical Medicine and Rehabilitation and the American Association of Neuromuscular & Electrodiagnostic Medicine.

  6. Addendum to Assessment: Prevention of Post-Lumbar Puncture Headaches

    August 2005

    Current guideline. Reaffirmed on February 9, 2008. See "Assessment: Prevention of Post-Lumbar Puncture Headaches" (November 2000).

  7. Pharmacological Treatment of Migraine Headache in Children and Adolescents

    December 2004

    Update in progress.

  8. Evaluation of Children and Adolescents with Recurrent Headaches

    August 2002

    Current guideline. Reaffirmed on October 18, 2003, October 15, 2005, August 2, 2008, July 13, 2013, and July 16, 2016. .

  9. Prevention of Post-Lumbar Puncture Headaches

    October 2000

    Reaffirmed on July 19, 2008. See "Addendum: Prevention of Post-Lumbar Puncture Headaches" (August 2005).

  10. Electroencephalogram in the Evaluation of Headache

    July 1995

    Current guideline. Reaffirmed on October 28, 2006, July 10, 2010, and August 9, 2014.

Questions?

Email guidelines@aan.com

Call (800) 879-1960 or (612) 928-6000 (international)

Top

Footer